home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Test Article Management and Characterization for Drugs and Devices

 
  July 10, 2012  
     
 
ComplianceOnline, OnlineEvent
2012-09-11


 You will learn the correct way to use GMP characterization data in a GLP study, understand how to characterize a medical device as a test article, learn the common mistakes made in test article characterization and the basic requirements for drug and device stability testing.

Why Should You Attend:

The presentation will begin with a review of GLP requirements for test and control article characterization, regardless of whether the article is a drug or device. It will address the study director's responsibilities and sponsor responsibilities in test article characterization. Attendees will learn the best practices for managing GMP characterizations, stability, and certificates of analysis. Special attention is given to the testing that must be performed to show that no test material carried over into control materials. Carryover has become one of FDA’s target areas in recent years because of the serious effect it has on drug safety results. The presentation treats carryover as a special topic in test article/control article characterization. The presenter also emphasizes the importance of control article characterization.

 Areas Covered in the Seminar:

  • What are the recommended procedures for chemical and physical characterization of drugs/devices in safety testing.
  • What are the basic requirements of test article characterization.
  • How to manage carry-over from test to control article
  • How to use GMP test article characterization and the certificate of analysis for a GLP study
  • How to define a device test article
  • How to characterizing medical devices
  • Stability testing for drugs and devices
  • How to document test article usage and distribution

 

 
 
Organized by: Complianceonline
Invited Speakers: Anne Maczulak, PhD, RQAP-GLP, is an independent consultant at Acorn GLP Consulting. She has more than 20 years experience as sponsor, study director, or participating scientist in preclinical studies. Anne works with established companies, startups, and universities in need of guidance in GLP regulations. She has presented webinars for FDA and training courses for the Society of Quality Assurance. She audits laboratories that conduct nonclinical studies and/or bioanalysis and provides on-site as well as remote training in GLP.
 
Deadline for Abstracts: 2012-09-10
 
Registration:
$249.00One Dial-in One Attendee
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.